• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.22% Nasdaq Up2.00%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NCM
    5.91 Up 0.10(1.72%) 4:00PM EDT
    |After Hours : 5.91 0.00 (0.00%) 4:33PM EDT
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Net Income (123,145) (111,518) (46,732)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation11,790  306  54  
    Adjustments To Net Income19,475  27,657  5,953  
    Changes In Accounts Receivables(2,775)(882) -  
    Changes In Liabilities(4,423)14,078  7,291  
    Changes In Inventories(29,189)(7,771) -  
    Changes In Other Operating Activities810  (2,871)(885)
    Total Cash Flow From Operating Activities (127,457) (81,001) (34,319)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(2,777)(1,489)(346)
    Investments11,508  (11,508) -  
    Other Cash flows from Investing Activities -   -   -  
    Total Cash Flows From Investing Activities 8,731   (12,997) (346)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock119,747  112,586  75,684  
    Net Borrowings125,000   -   -  
    Other Cash Flows from Financing Activities(15) -   -  
    Total Cash Flows From Financing Activities 244,732   112,586   75,684  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 126,006   18,588   41,019  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.